health
Heartburn / Acid Reflux
Adverse effectHeartburn / Acid Reflux is an adverse digestive outcome involving a burning sensation, reflux, or upper-abdominal discomfort. It describes irritation associated with stomach contents moving upward or with direct irritation of the digestive tract.
See how Heartburn / Acid Reflux is presented across health-related evidence and effects.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Turkey TailsupplementUnclear
Based on one study. Strongest study: a small pilot study.
Heartburn has been reported.
Open the Turkey Tail pageFastingpracticesimple.meter.userReports
Based on 2 studies.
Open the Fasting page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on2 listedHighest probability
- →SupplementsTurkey TailCertaintyLowSourceClinical1 other source
Heartburn has been reported.
Who was studied
- People with a condition
- Breast Cancer
Open Turkey TailStudy result
Mild adverse events: heartburn, heart palpitations, constipation, chest pain, fever with radiation dermatitis, cold/flu-like symptoms (7 mild total)
- →PracticesFastingCertaintyLowSourceAnecdotal2 other sources
Empty-stomach acid secretion and large meals after a fast can cause reflux or heartburn in some people.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Heartburn / Acid Reflux is an adverse digestive outcome involving a burning sensation, reflux, or upper-abdominal discomfort. It describes irritation associated with stomach contents moving upward or with direct irritation of the digestive tract. Different interventions may be linked to this outcome through different pathways, so reflux symptoms and broader digestive discomfort are related but not identical experiences.
How interventions help
Interventions linked with heartburn or acid reflux appear to do so through more than one pathway. Some may directly irritate the gastrointestinal tract, leading to epigastric burning, dyspepsia, reflux, or indigestion. Others may promote reflux by relaxing or reducing pressure in the lower esophageal sphincter, which can make it easier for stomach contents to move upward. Smoking may also increase symptoms by impairing mucosal defenses as well as reducing lower-esophageal-sphincter pressure.
The reported symptoms are not limited to classic heartburn: they also include abdominal discomfort, diarrhea, mild gastric pyrosis, and gastroesophageal reflux disease. This means that an intervention associated with general gastrointestinal intolerance may still be relevant to someone monitoring reflux symptoms, even when heartburn is not the only complaint.
The findings do not establish a consistent dose, duration, onset, or persistence pattern, so they cannot show whether symptoms depend on continued use or remain after an intervention is stopped. They also do not specify a particular health status for the people considered, limiting conclusions about which groups may be more susceptible.
Choosing guidance
When choosing among these options, first consider whether the product or activity has a plausible route to aggravate reflux, such as direct gastrointestinal irritation, effects on the lower esophageal sphincter, or abdominal compression. This matters more than treating every listed option as equivalent: Iron, Caffeine, and Cigarette Smoking are described through pharmacology references, while several other options are supported by clinical findings, anecdotal reports, or theoretical rationale.
Clinical evidence is generally more directly informative for people than anecdotal or theoretical evidence, but the studied health status is not specified. As a result, it is unclear how well the findings apply specifically to people with established heartburn or acid reflux. Evidence also varies in design, so a clinical review, a controlled trial, and a small pilot study should not be interpreted as interchangeable. Apparent differences between options may therefore reflect differences in study methods as well as genuine differences in reflux risk.
The information does not establish a reliable onset time, a required duration of use, or a dose at which one option becomes preferable to another. It does indicate that larger servings or higher doses may matter for some products, and that taking certain products without food, soon after meals, or while using reflux-provoking exercise positions may be relevant. Options with dose-related or meal-related concerns may be less suitable for people who notice symptoms soon after taking a product, while activity-related entries are most relevant to people whose symptoms occur during cycling or yoga. Any choice should therefore account for the person’s symptom pattern, intended use, and the type of evidence supporting the option.